Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib

Clinical trial NCT01876641 · TERMINATED

Trial details

NCT number: NCT01876641
Sponsor: Mohammed M Milhem
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Melanoma BRAF-mutated Metastatic Melanoma V600EBRAF-mutated Metastatic Melanoma

Start date: 2013-10-01
Primary completion: 2018-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.